Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | NAAA | Q02083 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16329456 | 0.86 | MAPT (0.47) | TSHRALDH1A1THRBMAPTMAPK1 | |
| SCHEMBL812979 | 0.81 | ALDH1A1 (0.52) | TSHRALDH1A1MAPTHPGDNAAA | |
| SCHEMBL813357 | 0.81 | ALDH1A1 (0.52) | TSHRALDH1A1MAPTHPGDNAAA | |
| SCHEMBL526157 | 0.81 | ALDH1A1 (0.52) | TSHRALDH1A1MAPTHPGDNAAA | |
| SCHEMBL552606 | 0.81 | ALDH1A1 (0.52) | TSHRALDH1A1MAPTHPGDNAAA | |
| SCHEMBL12376747 | 0.81 | THRB (0.33) | ALDH1A1THRBMAPT | |
| SCHEMBL1296295 | 0.80 | MAPT (0.49) | TSHRALDH1A1MAPTHPGDNAAA | |
| SCHEMBL10290651 | 0.79 | ALDH1A1 (0.42) | TSHRALDH1A1MAPTHPGDNAAA | |
| SCHEMBL880000 | 0.78 | ALDH1A1 (0.50) | TSHRALDH1A1HPGDNAAAL3MBTL1 | |
| SCHEMBL13739316 | 0.78 | ALDH1A1 (0.50) | TSHRALDH1A1HPGDNAAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2520579-B1 | A silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | RICOH CO LTD (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-8871861-B2 | Silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | RICOH COMPANY, LTD. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-8871861-B2 | Silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | RICOH COMPANY, LTD. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20120283378-A1 | A SILICONE COMPOUND, PHOTOCURABLE LIQUID INK USING THE SILICONE COMPOUND, AND METHOD OF MANUFACTURING THE INK | RICOH COMPANY, LTD., (JP) | 2012-11-08 | — | — | US | disclosed |
| EP-2520579-A2 | A silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink | Ricoh Company, Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283378-A1 | A SILICONE COMPOUND, PHOTOCURABLE LIQUID INK USING THE SILICONE COMPOUND, AND METHOD OF MANUFACTURING THE INK | DOT1L, L3MBTL3, KDM7A | TSHR 3732/4885ALDH1A1 2204/4885THRB 4064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.